60 related articles for article (PubMed ID: 8032075)
1. Polymorphous ventricular tachycardia after intracoronary papaverine: a report of 3 cases.
Zhang X; Shen W; Cai X; Zheng A
Chin Med Sci J; 1993 Dec; 8(4):248-9. PubMed ID: 8032075
[TBL] [Abstract][Full Text] [Related]
2. Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease.
Nakayama M; Tanaka N; Sakoda K; Hokama Y; Hoshino K; Kimura Y; Ogawa M; Yamashita J; Kobori Y; Uchiyama T; Aizawa Y; Yamashina A
Circ J; 2015; 79(3):530-6. PubMed ID: 25746536
[TBL] [Abstract][Full Text] [Related]
3. Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine.
Talman CL; Winniford MD; Rossen JD; Simonetti I; Kienzle MG; Marcus ML
J Am Coll Cardiol; 1990 Feb; 15(2):275-8. PubMed ID: 2299067
[TBL] [Abstract][Full Text] [Related]
4. Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve.
Kern MJ; Deligonul U; Serota H; Gudipati C; Buckingham T
Cathet Cardiovasc Diagn; 1990 Apr; 19(4):229-36. PubMed ID: 2334953
[TBL] [Abstract][Full Text] [Related]
5. QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine.
Inoue T; Asahi S; Takayanagi K; Morooka S; Takabatake Y
Cardiology; 1994; 84(1):9-13. PubMed ID: 7511988
[TBL] [Abstract][Full Text] [Related]
6. Sinus Standstill in a Patient after Intracoronary Papaverine Administration for a Coronary Fractional Flow Reserve.
Nauchi M; Sakai T; Yamawaki M; Ito Y
Int Heart J; 2018 May; 59(3):630-633. PubMed ID: 29681575
[TBL] [Abstract][Full Text] [Related]
7. Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases.
Nakayama M; Saito A; Kitazawa H; Takahashi M; Sato M; Fuse K; Okabe M; Hoshino K; Tanaka N; Yamashina A; Aizawa Y
Intern Med; 2012; 51(4):351-6. PubMed ID: 22333368
[TBL] [Abstract][Full Text] [Related]
8. Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation.
Goto M; Sato M; Kitazawa H; Takahashi M; Fuse K; Saito A; Okabe M; Aizawa Y
Intern Med; 2014; 53(15):1629-31. PubMed ID: 25088875
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine.
Jain A; Jenkins MG
Cathet Cardiovasc Diagn; 1989 Dec; 18(4):255-7. PubMed ID: 2605630
[TBL] [Abstract][Full Text] [Related]
10. Intracoronary papaverine induced myocardial lactate production in patients with angiographically normal coronary arteries.
Takeuchi M; Nohtomi Y; Kuroiwa A
Cathet Cardiovasc Diagn; 1996 Oct; 39(2):126-30. PubMed ID: 8922310
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic ventricular tachycardia induced by intracoronary injection of ioxaglate in a patient with borderline QT prolongation.
Emori T; Fujieda H; Ohe T
J Cardiovasc Electrophysiol; 1996 Oct; 7(10):962-6. PubMed ID: 8894938
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH
Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
[TBL] [Abstract][Full Text] [Related]
13. Serious ventricular dysrhythmias after intracoronary papaverine.
Wilson RF; White CW
Am J Cardiol; 1988 Dec; 62(17):1301-2. PubMed ID: 2461650
[No Abstract] [Full Text] [Related]
14. Does coronary flow reserve assessed by blood flow velocity analysis reflect absolute coronary flow reserve?
Takeuchi M; Nohtomi Y; Kuroiwa A
Cathet Cardiovasc Diagn; 1996 Jul; 38(3):251-4. PubMed ID: 8804781
[TBL] [Abstract][Full Text] [Related]
15. [Coronary reserve determination by intracoronary papaverine: effects of various doses on coronary circulation and hemodynamics].
Franz N; Modersohn D; Romaniuk P; Linss G
Z Gesamte Inn Med; 1991; 46(1-2):15-7. PubMed ID: 2038868
[TBL] [Abstract][Full Text] [Related]
16. Incessant ventricular tachycardia acutely controlled with intracoronary injection of radiographic contrast media.
Arias MA; Peinado R; Sánchez AM; Merino JL
Am J Emerg Med; 2006 May; 24(3):290-2. PubMed ID: 16635699
[TBL] [Abstract][Full Text] [Related]
17. [Inverse relationship between coronary flow velocity and myocardial oxygen extraction during intracoronary infusion of papaverine].
Mikuniya A; Higashiyama A; Mikami M; Fujino Y; Sasaki N; Sasaki M; Fukushi T; Narita T; Onodera K; Oike Y
J Cardiol; 1992; 22(2-3):549-56. PubMed ID: 1339814
[TBL] [Abstract][Full Text] [Related]
18. Abnormal coronary flow reserve in patients with angina pectoris and hypertensive left ventricular hypertrophy.
Shen W; Cai X; Zhang D; Zhang X; Zheng A; Gong L
Chin Med J (Engl); 1996 May; 109(5):376-80. PubMed ID: 9208495
[TBL] [Abstract][Full Text] [Related]
19. [Coronary flow after successful angioplasty in patients with acute myocardial infarction: comparison between coronary flow reserve by nicorandil and papaverine].
Izumi C; Kondo H; Tamura T; Inoko M; Kitaguchi S; Hirozane T; Himura Y; Iga K; Gen H; Konishi T
J Cardiol; 2000 Mar; 35(3):175-80. PubMed ID: 10808424
[TBL] [Abstract][Full Text] [Related]
20. Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease.
Aarnoudse W; Geven M; Barbato E; Botman KJ; De Bruyne B; Pijls NH
Am J Cardiol; 2005 Dec; 96(12):1627-30. PubMed ID: 16360347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
